Table of Contents Author Guidelines Submit a Manuscript
Autoimmune Diseases
Volume 2012, Article ID 321614, 8 pages
http://dx.doi.org/10.1155/2012/321614
Review Article

Evaluation of ENA-6 Profile by ELISA Immunoassay in Patients with Systemic Lupus Erythematodes

1Center for Genetics, Medical Faculty, University of Sarajevo, Cekalusa 90, Sarajevo, Bosnia and Herzegovina
2Department of Clinical immunology, KCUS, Sarajevo, Bosnia and Herzegovina
3Department of Biomedicine and Public Health, Faculty of Medicine, Osijek University, Osijek, Croatia

Received 27 April 2012; Accepted 8 August 2012

Academic Editor: Hiroshi Okamoto

Copyright © 2012 Izeta Aganovic-Musinovic et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. L. Jacobson, S. J. Gange, N. R. Rose, and N. M. H. Graham, “Epidemiology and estimated population burden of selected autoimmune diseases in the United States,” Clinical Immunology and Immunopathology, vol. 84, no. 3, pp. 223–243, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Marrack, J. Kappler, and B. L. Kotzin, “Autoimmune disease: why and where it occurs,” Nature Medicine, vol. 7, no. 8, pp. 899–905, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. M. R. Salaman, “A two-step hypothesis for the appearance of autoimmune disease,” Autoimmunity, vol. 36, no. 2, pp. 57–61, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. M. J. Townsend, J. G. Monroe, and A. C. Chan, “B-cell targeted therapies in human autoimmune diseases: an updated perspective,” Immunological Reviews, vol. 237, no. 1, pp. 264–283, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Tikly and S. V. Navarra, “Lupus in the developing world—is it any different?” Best Practice and Research: Clinical Rheumatology, vol. 22, no. 4, pp. 643–655, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Yasutomo, “Pathological lymphocyte activation by defective clearance of self-ligands in sytemic lupus erythematosus,” Rheumatology, vol. 42, no. 2, pp. 214–222, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. J. C. W. Edwards and G. Cambridge, “B-cell targeting in rheumatoid arthritis and other autoimmune diseases,” Nature Reviews Immunology, vol. 6, no. 5, pp. 394–403, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Dorner, A. M. Jacobi, and P. E. Lipsky, “B cells in autoimmunity,” Arthritis Research & Therapy, vol. 11, p. 247, 2009. View at Google Scholar
  9. S. Yurasov, T. Tiller, M. Tsuiji et al., “Persistent expression of autoantibodies in SLE patients in remission,” Journal of Experimental Medicine, vol. 203, no. 10, pp. 2255–2261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. S. M. Orton, A. Peace-Brewer, J. L. Schmitz, K. Freeman, W. C. Miller, and J. D. Folds, “Practical evaluation of methods for detection and specificity of autoantibodies to extractable nuclear antigens,” Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 2, pp. 297–301, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Mandel, M. Gurevich, R. Pauzner, N. Kaminski, and A. Achiron, “Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus,” Clinical and Experimental Immunology, vol. 138, no. 1, pp. 164–170, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Franceschini and I. Cavazzana, “Anti-Ro/SSA and La/SSB antibodies,” Autoimmunity, vol. 38, no. 1, pp. 55–63, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Migliorini, C. Baldini, V. Rocchi, and S. Bombardieri, “Anti-Sm and anti-RNP antibodies,” Autoimmunity, vol. 38, no. 1, pp. 47–54, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. B. B. Suh-Lailam, T. R. Chiaro, A. R. Wilson, and A. E. Tebo, “Evaluation of a high avidity anti-dsDNA IgG enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus,” Journal of Clinical and Experimental Pathology, vol. 4, no. 8, pp. 748–754, 2011. View at Google Scholar
  15. R. A. Sinico, B. Bollini, E. Sabadini, L. Di Toma, and A. Radice, “The use of laboratory tests in diagnosis and monitoring of systemic lupus erythematosus,” Journal of Nephrology, vol. 15, supplement 6, pp. S20–S27, 2002. View at Google Scholar · View at Scopus
  16. S. M. Orton, A. Peace-Brewer, J. L. Schmitz, K. Freeman, W. C. Miller, and J. D. Folds, “Practical evaluation of methods for detection and specificity of autoantibodies to extractable nuclear antigens,” Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 2, pp. 297–301, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. E. C. LeRoy and T. A. Medsger Jr., “Criteria for the classification of early systemic sclerosis,” Journal of Rheumatology, vol. 28, no. 7, pp. 1573–1576, 2001. View at Google Scholar · View at Scopus
  18. Registrolesaf, “Registrolesaf. Features of patients with systemic lupus erythematosus and antiphospholipid syndrome registered by rheumatologists and internists,” Reumatología Clinica, vol. 2, pp. 131–136, 2006. View at Google Scholar
  19. G. P. Tri, R. C. W. Wong, and S. Adelstein, “Autoantibodies to extractable nuclear antigens: making detection and interpretation more meaningful,” Clinical and Diagnostic Laboratory Immunology, vol. 9, no. 1, pp. 1–7, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. 1997 Update of the 1982 American College of Rheumatology Revised Criteria for Classification of Systemic Lupus Erythematodes, American College of Rheumatology.
  21. S. Malik, G. R. Bruner, C. Williams-Weese et al., “Presence of anti-La autoantibody is associated with a lower risk of nephritis and seizures in lupus patients,” Lupus, vol. 16, no. 11, pp. 863–866, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. Blood Tests, The Lupus Site, 2009, http://www.uklupus.co.uk/tests.html.
  23. K. F. Thomson, A. Murphy, M. J. D. Goodfield, and S. A. Misbah, “Is it useful to test for antibodies to extractable nuclear antigens in the presence of a negative antinuclear antibody on Hep-2 cells?” Journal of Clinical Pathology, vol. 54, no. 5, p. 413, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Hiroshi, “Immunity. The measuring method of anti-ENA antibody,” Modern Medical Laboratory, vol. 31, no. 6, pp. 495–499, 2003. View at Google Scholar
  25. P. Eissfeller, M. Sticherling, D. Scholz et al., “Comparison of different test systems for simultaneous autoantibody detection in connective tissue diseases,” Annals of the New York Academy of Sciences, vol. 1050, pp. 327–339, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Lyons, S. Narain, C. Nichols, M. Satoh, and W. H. Reeves, “Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease,” Annals of the New York Academy of Sciences, vol. 1050, pp. 217–228, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. M. A. Fernando and D. A. Isenberg, “How to monitor SLE in routine clinical practice,” Annals of the Rheumatic Diseases, vol. 64, no. 4, pp. 524–527, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. I. Siddiqui, J. Farooqi, F. Ghani, A. Habib, and D. A. Shariff, “Pattern of anti-ENA (extractable nuclear antigens) antibodies in different clinical desorders, a clinical laboratory based study,” International Journal of Pathology, vol. 5, no. 2, pp. 67–71, 2007. View at Google Scholar
  29. H. C. Nossent and O. P. Rekvig, “Is closer linkage between systemic lupus erythematosus and anti-double-stranded DNA antibodies a desirable and attainable goal?” Arthritis Research and Therapy, vol. 7, no. 2, pp. 85–87, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Topic, D. Primorac, and S. Jankovic, “Medicinsko biohemijska dijagnostika u klinickoj praksi,” Medicinska Naklada Zagreb, pp. 295–296, 2004. View at Google Scholar
  31. H. C. Sox, M. A. Blatt, M. C. Higgins, and K. Marton, Medical Decision Making, Butterworth, London, UK, 1989.
  32. X. Zhou, N. A. Obuchowski, D. K. McClish, X. Zhou, N. A. Obuchowski, and D. K. McClish, Statistical Methods in Diagnostic Medicine, John Wiley and Sons, New York, NY, USA, 2002.
  33. D. J. Hand, “Measuring classifier performance: a coherent alternative to the area under the ROC curve,” Machine Learning, vol. 77, no. 1, pp. 103–123, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. M. S. Pepe, The Statistical Evaluation of Medical Tests for Classification and Prediction, Oxford University Press, New York, NY, USA, 2003.
  35. B. Hanczar, J. Hua, C. Sima, J. Weinstein, M. Bittner, and E. R. Dougherty, “Small-sample precision of ROC-related estimates,” Bioinformatics, vol. 26, no. 6, pp. 822–830, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. M. C. Hochberg, “Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 40, no. 9, p. 1725, 1997. View at Google Scholar · View at Scopus
  37. K. Smykał-Jankowiak and Z. I. Niemir, “Structure and function of complement protein C1q and its role in the development of autoimmune diseases,” Postępy Higieny i Medycyny Doświadczalnej, vol. 63, pp. 134–141, 2009. View at Google Scholar · View at Scopus
  38. M. Olesińska, H. Chwalińska-Sadowska, E. Więsik-Szewczyk, P. Mielnik, and J. Zabek, “Clinical manifestation of systemic lupus erythematosus in patients with antiribosomal P protein antibodies,” Polskie Archiwum Medycyny Wewnetrznej, vol. 120, no. 3, pp. 76–81, 2010. View at Google Scholar · View at Scopus
  39. S. Agarwal, J. Harper, and P. D. W. Kiely, “Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus,” Lupus, vol. 18, no. 5, pp. 407–412, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. T. T. Tran and D. S. Pisetsky, “Systemic lupus erythematosus and related diseases,” Autoimmunity, vol. 37, no. 4, pp. 301–304, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. S. S. Copple, T. B. Martins, C. Masterson, E. Joly, and H. R. Hill, “Comparison of three multiplex immunoassays for detection of antibodies to extractable nuclear antibodies using clinically defined sera,” Annals of the New York Academy of Sciences, vol. 1109, pp. 464–472, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Ippolito, D. J. Wallace, D. Gladman et al., “Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity,” Lupus, vol. 20, no. 3, pp. 250–255, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Mosca, C. Tani, M. Aringer et al., “European league against rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies,” Annals of the Rheumatic Diseases, vol. 69, no. 7, pp. 1269–1274, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. D. A. Isenberg, J. J. Manson, M. R. Ehrenstein, and A. Rahman, “Fifty years of anti-ds DNA antibodies: are we approaching journey's end?” Rheumatology, vol. 46, no. 7, pp. 1052–1056, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. C. C. Mok, L. Y. Ho, H. W. Leung, and L. G. Wong, “Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus,” Translational Research, vol. 156, no. 6, pp. 320–325, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Bigler, H. Hopfer, D. Danner, M. Schaller, M. J. Mihatsch, and M. Trendelenburg, “Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis,” Nephrology Dialysis Transplantation, vol. 26, no. 4, pp. 1220–1228, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. R. A. Sinico, L. Rimoldi, A. Radice, L. Bianchi, B. Gallelli, and G. Moroni, “Anti-C1q autoantibodies in lupus nephritis,” Annals of the New York Academy of Sciences, vol. 1173, pp. 47–51, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Petri, “Disease activity assessment in SLE: do we have the right instruments?” Annals of the Rheumatic Diseases, vol. 66, supplement 3, pp. iii61–iii64, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Rahman and D. A. Isenberg, “Systemic lupus erythematosus,” The New England Journal of Medicine, vol. 358, no. 9, pp. 929–939, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. L. B. Tucker, “Making the diagnosis of systemic lupus erythematosus in children and adolescents,” Lupus, vol. 16, no. 8, pp. 546–549, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. D. P. D'Cruz, M. A. Khamashta, and G. R. Hughes, “Systemic lupus erythematosus,” The Lancet, vol. 369, no. 9561, pp. 587–596, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. M. M. A. Fernando and D. A. Isenberg, “How to monitor SLE in routine clinical practice,” Annals of the Rheumatic Diseases, vol. 64, no. 4, pp. 524–527, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. F. G. Joseph and N. J. Scolding, “Neurolupus,” Practical Neurology, vol. 10, no. 1, pp. 4–15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. L. H. Mackillop, S. J. Germain, and C. Nelson-Piercy, “Systemic lupus erythematosus,” British Medical Journal, vol. 335, no. 7626, pp. 933–936, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. R. Madhok and O. Wu, “Systemic lupus erythematosus,” American Family Physician, vol. 76, no. 9, pp. 1351–1353, 2007. View at Google Scholar · View at Scopus
  56. C. C. Mok, “Biomarkers for lupus nephritis: a critical appraisal,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 638413, 11 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. K. Op De Beéck, P. Vermeersch, P. Verschueren et al., “Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis,” Autoimmunity Reviews. In press.